(2E)-1-(3,4-dichlorophenyl)-3-(3-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

(R)-2-Methylmorpholine, 95.0%, 250mg

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidin-2-one, 97%, 250mg

2,3-Dichloro-4-methylphenylboronic acid, 98%, 1g

N,N-Dimethyl-n-tetradecylamine, 90.0%, 500ml

(5,6-dimethyl-1H-benzimidazol-1-yl)acetonitrile, 95.0%, 10g

Tert-butyl7-oxo-1-azaspiro[3.5]nonane-1-carboxylate, 98%, 1g

4-tert-Butyl-N-[(piperidin-3-yl)methyl]benzamide hydrochloride, 90%, 250mg

Glycine, 500 g

Diethylenetriamine, min. 98%, for synthesis, 2.5 L, glass packaging

5-Chloro-1-(4-chlorophenyl)-1-oxopentane, 97.0%, 1g

Imidazo[1,2-a]pyrimidine-2-carboxaldehyde, 3-bromo-, 95%, 250mg

3-Bromo-1-ethyl-1H-indazole, 95.0%, 1g